|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00648 SOFTMEDX
Nominal 
() | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 34,075 | -4.741% | 68,243 | 54,639 | 51,340 | 33,765 |
| Cost of Sales | (24,644) | 1.466% | (45,650) | (36,241) | (30,215) | (20,028) |
| Gross Profit | 9,431 | -17.870% | 22,593 | 18,398 | 21,125 | 13,737 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (2,815) | (16,613) | -- | (494) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | (4,725) | -- | |
| Other Non-operating Items | -- | -- | (20) | 328,026 | 19,075 | (1,070) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 5,784 | 20.550% | 9,448 | 327,954 | 14,369 | (16,632) | |
| Taxation | (1,136) | -21.384% | (2,498) | (1,637) | (1,858) | (2,593) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 4,648 | 38.622% | 6,950 | 326,317 | 12,511 | (19,225) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 40 | -85.714% | 1,329 | 1,133 | 12,577 | 15,511 |
| Depreciation & Amortisation | 335 | 40.167% | 425 | 592 | 1,189 | 2,040 |
| Directors' Emoluments | -- | -- | 456 | 316 | 215 | 12,679 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 4.400 | -78.641% | 24.000 | 2,000.000 | 76.000 | -118.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.187 | 0.238 | (0.014) | (0.009) |
| NBV per share ($) | 0.301 | -- | 0.258 | 0.151 | (19.866529) | (20.633989) |
| Remarks: | Real time quote last updated: -- |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 4,648 |
| %Change | 38.622% |
| EPS / (LPS) | HKD 0.044 |
| NBV Per Share ($) | HKD 0.301 |